The financing of the Dea Group is being restructured as part of the sale of RWE Dea AG by RWE AG to LetterOne. The central component of this new financing structure is an oil and gas reserve-based acquisition loan agreement (reserve based lending facility agreement).

A team from CMS in Germany and the UK headed by lead partner Dr Thomas de la Motte advised RWE Dea AG as the target company on all aspects of the new financing structure.

Headquartered in Hamburg, RWE Dea AG (to be known in future as DEA Deutsche Erdoel AG) is an exploration and production company for gas and oil which operates internationally and has been part of RWE since 1988. It posted external revenues of EUR 2.1 billion in 2013 and employed more than 1,400 people. RWE is one of the top five electricity and gas providers in Europe, with around 60,000 employees and revenues of EUR 54 billion in the 2013 financial year. International investment company LetterOne of Luxembourg had assets under management totalling USD 29 billion at the end of 2013.

CMS Hasche Sigle

Dr. Thomas de la Motte, Lead
Dr. Anja Hasselmann-Thiede
Verena Burow
Dr. Andreas Keller, all Finance
Dr. Hilke Herchen
Dr. Ronald Brettner, both Stock Corporation Law, M&A
Dr. Heino Büsching
Dr. Olaf Thießen, both Tax
Dr. Tim Reher
Dr. Ann-Christin Richter, both Competition
Dr. Konrad Walter, Public Law, all Hamburg
Paul Caesar Rode, Corporate, Duesseldorf

CMS Cameron McKenna

Gordon Hay
Tabasam Faqir
Jenny Allan (all Finance)